These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 7347694
1. Bacampicillin twice daily: a dose-response study in acute exacerbations of chronic bronchitis. Maesen FP, Davies BI, Sjövall J. Eur J Respir Dis; 1981 Dec; 62(6):434-40. PubMed ID: 7347694 [Abstract] [Full Text] [Related]
2. Twice daily dosage of bacampicillin in chronic bronchitis. A double-blind study. Davies BI, Maesen FP, Brombacher PJ, Sjövall J. Scand J Respir Dis; 1978 Oct; 59(5):249-56. PubMed ID: 32615 [Abstract] [Full Text] [Related]
3. Erythromycin and bromhexine in acute exacerbations of chronic bronchitis. A study on sputum penetration and clinical effectiveness. Maesen FP, Davies BI, Brouwers J, Rubingh G. Eur J Respir Dis; 1982 Jul; 63(4):325-9. PubMed ID: 6981522 [Abstract] [Full Text] [Related]
4. Comparison of three different doses of bacampicillin given twice daily to patients with acute exacerbations of chronic bronchitis in a clinical dose-response study. Maesen FP, Davies BI, Sjövall J. J Antimicrob Chemother; 1981 Nov; 8 Suppl C():115-8. PubMed ID: 7033201 [No Abstract] [Full Text] [Related]
5. [The efficacy of a maintenance dose of 100 mg doxycycline (Vibramycin) daily in bacterial infections of chronic bronchitis (author's transl)]. Eicke R, Genz U, Bartmann K, Koch G. Med Klin; 1978 Dec 15; 73(50):1778-9. PubMed ID: 31554 [Abstract] [Full Text] [Related]
6. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis. Grossman RF. Postgrad Med J; 1992 Dec 15; 68 Suppl 3():S30-6; discussion S36-7. PubMed ID: 1287616 [Abstract] [Full Text] [Related]
10. Comparison of bacampicillin twice daily and ampicillin four times daily in treatment of acute exacerbations of chronic bronchitis. Chodosh S. Rev Infect Dis; 1981 Sep 15; 3(1):140-9. PubMed ID: 7012995 [Abstract] [Full Text] [Related]
11. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis. Paster RZ, McAdoo MA, Keyserling CH, Nemeth MA, Tack KJ, Griffin TJ. Int J Clin Pract; 2000 Jun 15; 54(5):293-9. PubMed ID: 10954955 [Abstract] [Full Text] [Related]
15. The clinical efficacy and safety of bacampicillin twice daily in comparative studies. Blomqvist M, Hedström SA. J Int Med Res; 1987 Jun 15; 15(1):32-43. PubMed ID: 3545941 [Abstract] [Full Text] [Related]
16. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis. DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D. Respir Med; 2000 Nov 15; 94(11):1029-37. PubMed ID: 11127487 [Abstract] [Full Text] [Related]
17. Lower respiratory tract infections treated with bacampicillin: a dose comparison. Sjövall J. J Int Med Res; 1977 Nov 15; 5(5):313-21. PubMed ID: 913859 [Abstract] [Full Text] [Related]
18. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ. Clin Ther; 1999 Jan 15; 21(1):172-88. PubMed ID: 10090434 [Abstract] [Full Text] [Related]
19. A single dose of sulfametopyrazine versus 7 days of ampicillin in acute on chronic bronchitis. Anderson G, Peel ET, Payne H, Ruth P. Br J Dis Chest; 1985 Jul 15; 79(3):258-61. PubMed ID: 3893511 [Abstract] [Full Text] [Related]